Lazard Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-490	Closed	-$82K	–	2549
2023 Q3	$82K	Buy	490 +265	+118%	+$44.3K	﹤0.01%	1698
2023 Q2	$48K	Buy	+225	New	+$48K	﹤0.01%	1849
2022 Q2	–	Sell	-688	Closed	-$87K	–	2631
2022 Q1	$87K	Buy	+688	New	+$87K	﹤0.01%	1460